Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Change in Account Payables (2020 - 2025)

Bio Essence has reported Change in Account Payables over the past 6 years, most recently at $37272.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 359.39% year-over-year to $37272.0; the TTM value through Dec 2025 reached $30141.0, up 470.2%, while the annual FY2025 figure was $30141.0, 470.2% up from the prior year.
  • Change in Account Payables for Q4 2025 was $37272.0 at Bio Essence, up from -$85.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $46612.0 in Q2 2024 and troughed at -$27511.0 in Q3 2024.
  • A 5-year average of $1121.1 and a median of $740.0 in 2021 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: tumbled 3662.02% in 2021 and later skyrocketed 2955.18% in 2022.
  • Year by year, Change in Account Payables stood at $4453.0 in 2021, then crashed by 681.09% to -$25876.0 in 2022, then surged by 88.5% to -$2977.0 in 2023, then plummeted by 382.67% to -$14369.0 in 2024, then skyrocketed by 359.39% to $37272.0 in 2025.
  • Business Quant data shows Change in Account Payables for BIOE at $37272.0 in Q4 2025, -$85.0 in Q3 2025, and -$13415.0 in Q2 2025.